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1. Introduction 
Neural tube defects (NTD) are serious birth defects of the brain and spine, occurring when 
the neural tube doesn’t form or close completely. They are among the most frequent 
congenital malformations, affecting 300,000 pregnancies worldwide. Two forms of NTDs, 
spina bifida and anencephaly, account for 90% of all cases (Centers for Disease Control, 
CDC, 1989). 
Studies had proven that supplementation of women of childbearing age with folic acid can 
prevent up to 70% of all cases of NTDs (Laurence et al 1981, MRC Vitamin Study Research 
Group 1991). These researches led to international recommendations that all women of 
childbearing age consume 400 micrograms of folic acid daily for the prevention of neural 
tube defects at least 1 month before and throughout the first trimester of pregnancy (CDC 
1992, Institutes of Medicine 1998, WHO 2002). Three potential approaches were advocated 
to increase level of folic acid consumption among the general population: fortification of 
food supply, improvement of dietary habits and use of dietary supplements (CDC, 1992). In 
some countries such as Canada and the USA, these recommendations led to the fortification 
of all enriched grain products with folic acid. This action decreased the occurrence of spina 
bifida by 31% and anencephaly by 16% (CDC 2004) and thus was considered as a partial 
success. As for the change in eating habits, meeting dietary recommendations for grain 
intake is an important step to achieving the recommended daily intake for folic acid. Studies 
have shown that non pregnant women of childbearing age reported an average daily 
consumption of 128 mcg of folic acid, representing only 32 percent of the daily 
recommended amount (Yang et al. 2007). These facts imply that most women still need to 
daily consume a dietary supplement containing folic acid at the recommended dose (400 µg) 
in order to prevent pregnancies with NTDs. Despite all this, several studies have shown a 
low consumption of folic acid supplements worldwide: numbers vary from prevalence as 
low as 7.5% in Lebanon (Nasr Hage et al 2011) to the highest percentage of 40 % in Canada 
and the USA (Morin et al. 2002; Petrini et al, 2008). These percentages remain far from the 
“Healthy people 2010” goal aiming that a minimum of 80% of women of childbearing age 
consume at least 400 mcg of folic acid daily in the periconception period. Levels of 
awareness and knowledge have been studied extensively in women of childbearing age in 
order to explain the low prevalence of folic acid intake with variable results in different 
countries. Although these levels of awareness and knowledge were thought to explain low 
levels of folic acid consumption, a systematic review of the literature showed that variable 
interventions on folic acid increased women’s awareness from 60% to 72% and knowledge 
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from 21% to 45%. At the same time, levels of folic acid consumption increased only from 
14% to 23% showing a positive but suboptimal impact (Chivu et al. 2007). As Green and 
Kreuter say “changes in knowledge and awareness alone cannot be assumed to translate 
into changes in behavior” (Green and Kreuter, 1991). There is still a gap between awareness 
and behavior on one side and usage of folic acid on the other side. This gap could be 
explained by determinants of behavioral change such as unplanned pregnancies, perceived 
barriers for taking folic acid pills, lack of time, level of education, age group and culture. 
This chapter will discuss the preventive role of folic acid in the development of neural tube 
defects and the recommendations concerning its consumption. Factors related to folic acid 
knowledge, attitude and behavior will be analyzed as well as suggestions made for effective 
strategies aiming to improve its usage among women of childbearing age. 
2. Role of folic acid in the prevention of NTDs 
2.1 Folic acid as a vitamin 
Folate, also known as vitamin B9, is a water-soluble B vitamin that occurs naturally in food. It 
is an essential nutrient that humans can not synthesize. Folic acid is the synthetic form of folate 
that is found in supplements and added to fortified foods. Folate is found naturally in a wide 
variety of foods particularly leafy green vegetables such as spinach, asparagus and lettuce, 
grains such as beans, peas and lentils, fruits such as orange, cantaloupe and melon, kidney, 
liver, egg yolk and yeast. Most folates have many molecules of glutamic acid; they have to be 
converted to monoglutamate to be absorbed in the intestine. The synthetic form has one 
molecule of glutamic acid making it more bioavailable than the natural form. Folate is critically 
important for fetal development. It has a role in DNA synthesis, acts as a cofactor for many 
essential cellular reactions and is implicated in the metabolism of several amino acids 
especially in the conversion of homocysteine to methionine; thus, the need for folate increases 
during periods of rapid tissue growth such as in pregnancy. When folate is insufficient, DNA 
synthesis is impaired and cells are unable to successfully achieve mitosis. In addition, the 
methylation process of proteins, lipids and myelin is inhibited (Rosenblatt, 1995).  
2.2 Mechanism of NTD prevention with folic acid 
The mechanism by which folic acid prevents NTDs remains unknown. Many theories have 
been proposed. Genetic, nutritional, environmental factors or a combination of these play a 
role in the development of NTDs. The genetic theory of methylation was proposed by Blom 
et al (Blom et al, 2006). Problems during embryogenesis in the methylation of DNA, proteins 
and lipids are related to the development of NTDs. A mutation in the gene coding for the 
methylenetetrahydrofolate reductase enzyme, responsible of the generation of a methyl 
group essential for biosynthesis of methionine and nucleotides, is believed to contribute to 
fetal nervous system malformation such as spina bifida (Mills et al, 1995). This mutation 
accounts for one-fourth of NTDs suggesting that the protective effect of folate, reaching a 
70% reduction in NTDs, involves other environmental factors or gene-environment 
interactions (Posey et al, 1996). Other genes involved in the methylation cycle through 
remethylation or transsulfuration of homocysteine were also involved in the development of 
NTDs (Boyles et al, 2005). Besides the methylation theory, two other theories were proposed 
as genetic explanations for the relationship between folic acid and NTDs: the role of the 
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genes codifying to enzymes needed for nucleotide biosynthesis such as the polymorphism 
in methylenetetrahydrofolate dehydrogenase, and the role of the genes codifying proteins 
involved in the transport, capture and cell retention of folate (DeMarco et al, 2006; Beaudin 
and Stover, 2009). The role of nutrition in the development of NTDs has been studied. The 
relationship between folic acid deficiency and NTDs may be linked to lower gene 
expressions due to alteration in the methylation and synthesis of DNA (Zeisel, 2009). The 
daily consumption of folic acid reduced the level of homocysteine, a risk factor in the 
development of NTDs (Boyles et al, 2005). 
2.3 Evidence for prevention of NTDs with folic acid 
Early studies in the sixties and seventies suggested a role for diet in NTDS (Hibbard and 
Smithells 1965; Knox, 1972; Smithells et al 1976). In early eighties, two randomized 
controlled trials showed a reduction in the recurrence of NTDs with folic acid 
supplementation but these studies were criticized for their methodological limitations 
(Laurence et al 1981; Smithells et al, 1980). Further observational studies conducted in the 
eighties suggested that the consumption of folic acid by women of childbearing age is 
protective against NTDs in newborns (Bower and Stanley, 1989; Milunsky et al, 1989; 
Mulinar et al, 1988). This was confirmed by a randomized multicenter controlled trial 
showing that daily supplementation of women in childbearing age with folic acid reduced 
by 72% the risk of recurrence of NTDs (MRC Vitamin Study Research Group 1991). The 
conclusive proof of the preventive effect of folic acid for women with no NTD history came 
from a randomised controlled study conducted in Hungary that showed no NTD cases 
occured among 2104 women taking folic acid as compared with six cases among 2052 
pregnancies in the group not taking folic acid (Czeizel and Dudas, 1992). A meta-analysis 
study published in 2010 reviewed all observational and randomized studies evaluating the 
first occurrence and recurrence of NTDs and related mortalities in pregnancy. It concluded 
that folic acid intake reduced the recurrence of NTDs by 70% and the first occurrence of 
NTD by 62% (Blencowe et al, 2010). 
2.4 Recommendations for folic acid consumption in pregnancies 
All the data confirming the protective effect of folic acid against NTDs led to international 
recommendations concerning folic acid consumption in women of childbearing age. The 
Institutes of Medicine and CDC recommend the maternal consumption of 400 micrograms 
of synthetic folic acid daily at least 1 month before conception and during the first few 
months of pregnancy (CDC, 1992; Institute of Medicine, 1998). The Canadian college of 
medical geneticists recommended that a minimum dose of 0.8 mg/day of folic acid along 
with a well-balanced diet should be prescribed for women planning a pregnancy, starting 
before conception and for at least 10-12 weeks of pregnancy (Van Allen et al, 1993). Similar 
guidelines were issued by the Canadian college of obstetricians and gynecologists.   
The EUROCAT published a report about the “prevention of neural tube defects by 
periconceptional folic acid supplementation in Europe” (EUROCAT special report, updated 
version December 2009).  In most European countries where a policy exists, 
periconceptional folic acid supplements are recommended at a daily dose of 0.4 to 0.5 mg 
and the dose of 4 to 5 mg is reserved for women who have had a previous pregnancy 
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complicated with NTDs. Table 1 (adapted from the EUROCAT report) summarizes 
periconceptional  folic acid supplementation policies around Europe.  
Because half of all pregnancies in the United States are unplanned (Finer and Henshaw 
2006), and because NTDs occur often before a woman knows she is pregnant, the Centers for 
Disease Control and Prevention (CDC) recommends that all women who can become 
pregnant consume the recommended amount of folic acid daily, regardless of their 
pregnancy intentions (CDC, 2004).  
 
Country Folic acid policy 
 Status Year current policy 
introduced 
Austria Unofficial 1998 
Belgium Unofficial - 
Croatia Unofficial - 
Denmark Official 1997 
Finland Official  2004 
France Official 2000 
Germany Unofficial 1994 
Hungary Official 1996 
Ireland Official 1993 
Italy Official 2004 
Malta Dietary 1994 
Netherlands Official 1993 
Norway Official 1998 
Poland Official 1997 
Portugal Official 1998 
Slovenia Official 1998 
Spain Official 2001 
Sweden Official 1996 
Switzerland Official 1996 
UK Official 1992 
Ukraine Official 2002 
Table 1. Folic acid supplementation policy in European countries (until December 2007) 
3. Community interventions to increase folate intake 
Three ways were advocated in order to increase folate intake in women of childbearing age: 
improvement of dietary habits, fortification of food supply with folic acid and the use of 
folic acid supplements (CDC, 1992) 
3.1 Improvement of dietary habits 
Studies have shown that the average consumption of folate by women is not more than 
200µg/day (Gregory et al, 1990; Subar et al, 1989). Yang and colleagues calculated the 
average daily dietary intake of folate and folic acid by women of childbearing age in the 
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USA in 2001-2002. They found that the average daily consumption was 128 µg/day, 
representing 32% of the daily recommended amount (Yang et al, 2007). Knowing the 
importance of grain intake in achieving the recommended intake for folic acid, Briefel and 
Johnson reviewed national data in the USA on grain intake; they found that, in 1999-2000, 
only 24% of the population met the recommendation for daily servings of grains (Briefel and 
Johnson, 2004). The German Nutrition Report 2004 stated that the average daily intake of all 
women in Germany was 215µg/day, still below the reference value of 400µg/day 
(EUROCAT, 2009). Another study done by Heinz showed that 81% of women 18-40 years of 
age had a daily folic acid consumption of less than 150µg (Heinz et al, 2001 as in EUROCAT, 
2009). In Hungary, a dietary survey conducted in 2003-2004 showed that the average daily 
folic acid intake is 132.3µg/day (EUROCAT, 2009).The average daily natural folate intake of 
most women in different European countries ranges from 230 to 280 µg /day (Flynn et al, 
2009). A review done by Kumaniyka and his colleagues in 2000 on dietary behavioral 
changes in relation with nutrients such as fruits, vegetables and grains highlighted the 
difficulty of sustaining these behavioral modifications (Kumaniyka et al, 2000). These 
studies show that achieving the recommendations for folic acid consumption by food folates 
alone requires major dietary modifications unlikely to be achieved by women of 
childbearing age. Furthermore, one study tried to compare the effectiveness of the 3 
suggested interventions for meeting the recommendations on folic acid. A 12-week trial 
evaluated the changes in red blood cell folate in response to one of the following 
interventions: folic acid supplementation (400µg/day), natural food folates (400µg/day), 
fortified food (400µg/day), qualitative dietary advice and control diet. The study showed 
that the only interventions increasing significantly blood folate were food fortification and 
folic acid supplements. The increase in natural food folates did not translate into higher 
levels of blood folate, most probably because of the low bioavailability and stability of 
natural folates compared to the synthetic form (Cuskelly et al, 1996). 
3.2 Fortification of food with folic acid 
Regulations for mandatory food fortification with folic acid are currently in place in 53 
countries (CDC, 2010). In 1996, the United States Food and Drug Administration (FDA) 
issued a mandate to fortify all enriched grain products with folic acid, to be fully 
implemented in 1998. Food items covered by this mandate were mainly flour, corn meal, 
pasta and rice and they were fortified with 140µg/100g of cereal grains. At this level of 
fortification, women are expected to consume an average of 100µg daily of folic acid from 
fortified cereal grain products (FDA, 1996). Folic acid food fortification became mandatory 
in Canada and Costa Rica in 1998, with the fortification respectively of 150µg and 180µg 
/100g of enriched flour and uncooked cereal grains (Chen and Rivera, 2004; Ray, 2004). In 
2000, the Chilean ministry of health mandated that folic acid should be added at a level of 
2.2mg/kg to wheat flour (Hertrampf and Cortés, 2004). In June 2004, the Brazilian 
government introduced mandatory fortification of wheat and maize flour with 150µg/100 g 
(Almeida and Cardoso, 2010). A number of Middle Eastern countries, as well as Indonesia 
now fortify their flour. South Africa issued a mandate on food fortification in 2003 with 150 
µg of folic acid added to 100g of cereal grains (Sayed et al, 2008).The Australian government 
had agreed to fortification of flour and bread with folic acid, starting September 2009. In 
Europe mandatory fortification of a staple food with folic acid has been seriously considered 
in 8 countries (Denmark, Germany, Ireland, Northern Netherlands, Norway, Poland, 
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Switzerland and the UK), but debates are still going on. Until now, no European country has 
agreed to mandatory food fortification with folic acid (EUROCAT, 2009). At the same time, 
food voluntarily fortified with folic acid (such as breakfast cereals) is available in many 
European countries. These countries do not implement mandatory folic acid 
supplementation because, according to them, expected additional health benefits are not 
scientifically proven in clinical trial, because of feared health consequences and because of 
the issue of freedom of choice (Eichholzer et al, 2006).  
Studies have shown a positive impact of food fortification on blood folate concentrations 
and a reduction in the prevalence of NTDs in the USA (Boulet et al, 2008), in Canada 
(Godwin et al, 2008) and in Chile (Nazer et al, 2007).  
Measuring blood folate concentrations constitutes one way to evaluate the effect of food 
fortification programs. Folate deficiency is defined as a serum folate concentration <7nmol/l 
(3ng/ml) or a red blood cell folate concentration <315nmol/l (140ng/ml) (Crider et al, 2011). 
In The USA, median serum folate increased from 12.6µg/l in 1994 to 18.7 µg/l in 1998 after 
food fortification (Lawrence et al, 1999). In Canada,  a study conducted on 38,000 women in 
Ontario showed an increase in red blood cell folate from 527nmol/l to 741 nmole/l after 
food fortification (p<0.001) (Ray et al, 2002). In Chile, the mean serum concentrations and 
red blood cell folate increased respectively from 9.7 and 290nmol/l to 37.2 and 707nmol/l 
(p<0.0001) after mandatory fortification (Hertrampf et al, 2003). 
The main purpose for folic acid fortification was to reduce the occurence of NTDs and the 
associated mortality and morbidities. Many studies around the world evaluated the impact 
of food fortification on the prevalence of NTDs. In the USA, a report published by the CDC 
in 2004 found a reduction of 27% in spina bifida and anencephaly between 1995-1996 and 
1999-2000 (CDC, MMWR 2004). Different studies in the USA with different methodologies 
showed a decrease in the prevalence of NTDs between 19-32% after mandatory food 
fortification, reaching 23 to 54% for spina bifida and 11% to 16% for anencephaly (Boulet et 
al, 2008; Honein et al, 2001; Mathews, 2008; Williams et al, 2002). In Canada, studies have 
shown an even greater impact of food fortification than the impact shown in the USA. De Wals 
and collegues examined the NTD trends before and after food fortification in seven of ten 
Canadian provinces (De Wals et al, 2007, 2008). They showed a 46% reduction of NTDs and 
the magnitude of the decrease was higher for spina bifida (53%) than for anencephaly (38%) 
(De walls et al, 2007). Similar results were found in Chile, Argentina and Brazil with a 
reduction in the prevalence of NTDs by 19 to 55 % (Lopez-Camelo et al, 2010). In South Africa, 
Sayed and his collegues found a significant decline of 30.5% in the prevalence of NTDs (41.6% 
for spina bifida and 10.9% for anencephaly) following food fortification in 2003 (Sayed et al, 
2008). The differences found in the magnitude of the decline in NTD prevalence after food 
fortification among different countries depend on many factors such as the initial prevalence 
of NTDs, the initial folate status of the population, the consumption of fortified food by the 
population and the presence of birth defects surveillance systems (Crider et al, 2011). 
3.3 Folic acid supplements 
The third way suggested for increasing women consumption of folic acid is the use of 
supplements. In order to be effective, these supplements should be taken at least 1 month 
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before conception. This fact constitutes a limitation for the reliance on supplements as a 
primary public health program since in many countries, a high level of pregnancies are 
unplanned such as in  the USA where up to 50% of pregnancies are unplanned. 
International studies have shown a low level of compliance with folic acid supplements 
intake. In the USA, the percentage of women of childbearing age who consume folic acid 
supplements is low, slightly increasing from 28% in 1995 to 33% in 2005, up to 40% in 2007 
(CDC, 2008). Even in the Netherlands, where the percentage of planned pregnancies is 
estimated at 85%, only 36% of women take folic acid supplements during the 
periconceptional period (Meijer and De Walle, 2005). These low levels of intake were seen in 
different countries with the highest percentage of intake seen in Canada and the USA (40%) 
and the lowest percentages in Korea (10.3%), Thailand (9.7%) and Lebanon (7.5%) (Kim et al, 
2009; Morin et al, 2002; Nasr Hage et al, 2011; Nawapun and Phupong, 2007; CDC, 2008). 
4. Women’s knowledge and awareness concerning folic acid 
Of interest is the relationship between knowledge, awareness and adequate intake of folic 
acid. Awareness concerning folic acid is usually evaluated in response to the question “have 
you ever heard or read anything about folic acid?”; levels of awareness reported in the 
literature are very variable. In the USA, the March of Dimes Birth Defects Foundation 
reported national levels of awareness of 52% in 1995, increasing to 84% in 2005 (March of 
Dimes Birth Defects Foundation, 2005). The analysis done by the CDC showed that from 
2003 to 2007, levels of awareness were stagnant around 80% (79% in 2003 and 81% in 2007) 
(CDC, 2008). In Canada, awareness reached a percentage of 95% (French et al, 2003). Even in 
countries were folic acid intake is very low, women have usually high levels of awareness 
such as in Lebanon where 60% of women knew about folic acid but only 7.5% of them were 
using supplements adequately (Nasr Hage et al, 2011). Still in some countries, the number of 
women who have heard of folic acid is low, reaching 18% in Turkey (Turgul et al, 2009). 
Even though levels of awareness are acceptable in general with some exceptions, the gap lies 
in knowledge concerning the benefits of folic acid in NTDs prevention, the nutritional 
source of natural and synthetic folates and the adequate period of folic acid intake. National 
percentages in the USA showed that in 1995 only 4% of American women knew that folic 
acid help reduce the risk of birth defects. These numbers reached 24% in 2004 before 
decreasing to 19% in 2005. The same report stated that only 2% of American women 
identified the adequate period for folic acid intake, percentages reaching 12% in 2004 and 
dropping to 7% in 2005 (March of Dimes Birth Defects Foundation, 2005). A CDC report 
showed that knowledge concerning the adequate period of intake raise slightly to 12% in 
2007 (CDC, 2008). In Canada where the levels of awareness and intake are relatively high, 
only 25% of women studied in Vancouver knew that folic acid could prevent birth defects 
(French et al, 2003). As expected, low levels of knowledge were also found in countries with 
low levels of folic acid intake such as in Thailand where 25% of surveyed women knew that 
folic acid was something important and in Lebanon where 14% knew about the role of folic 
acid in NTD prevention and 25% knew about the adequate period for supplementation 
(Nasr Hage et al, 2011; Nawapun and Phupong, 2007). These numbers show that low intake 
of folic acid supplements is, at least partially related to lack of knowledge. This relationship 
was suggested by French and colleagues showing that 78% of the women in their study 
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indicated that, with knowledge of the benefits of folate, they would use folic acid 
supplements to reduce the risk of birth defects (French et al, 2003). Another survey done in 
2009 by the Gallup organization showed that when women were told the health benefits of 
taking a multivitamin with folic acid, 66% stated they were “willing” to buy and take a 
multivitamin and 22% stated they were “somewhat willing” (North Carolina Folic acid 
Council, 2009). A systematic review of the literature showed that variable interventions on 
folic acid increased women’s awareness from 60% to 72% and knowledge from 21% to 45%. 
At the same time, levels of folic acid consumption increased only from 14% to 23% showing 
a positive but suboptimal impact (Chivu et al. 2007). 
5. Folic acid intake 
5.1 Determinants of folic acid intake 
Studies measuring levels of folic acid intake looked for the factors related to behavior in order 
to explain low levels of usage. Daily folic acid intake is shown to be related to race/ethnicity, 
income, marital status, a positive attitude toward taking a physician’s advice, knowledge 
about the relationship between folic acid and birth defects, planning for the pregnancy, earlier 
pregnancies and earlier discussion between the women and her physician about vitamins 
(Ahluwalia et al, 2007; Carmichael et al, 2006; Cleves et al, 2004; French et al, 2003; Rosenberg 
et al, 2003). Studies also found that younger age is related to a lower intake of folic acid 
supplements (Morin et al, 2002; CDC, 2008; Timmermans et al, 2008).  
Studies in the USA showed that African-American and Hispanic women were less likely to 
use folic acid supplements than Caucasian women (Ahluwalia et al, 2007; Carmichael et al, 
2006; Cleves et al, 2004). Half of Hispanic women, and one third of African-American 
women aged 18-24 years, as compared to Caucasian women were taking folic acid 
supplements. An Irish study showed that women from Asia/Middle East, Eastern Europe, 
Africa and South America were less likely to use folic acid supplements than those from 
Western Europe and that the highest intake was among women from North America, 
Australia and New Zealand (McGuire et al, 2010). Ethnicity was also a factor influencing the 
uptake of folic acid supplements in the Netherlands, where non-western women were less 
likely to use supplements than western women (Timmermans et al, 2008).  
The relationship between low income and a lower intake of supplements has been 
highlighted in the literature. In their report published in 2008, Petrini and colleagues 
showed that the lowest prevalences of folic acid intake were seen in those with an annual 
household income of <$25,000 compared to those with >$50,000; these prevalences varied 
from 24% to 32% between the years 2003 and 2007 for women with the lowest income, and 
from 38% to 43% between 2003 and 2007 for women with the highest income (CDC, 2008). In 
Australia, a low income of less than 30,000$ was also associated with low levels of 
supplements intake (Forster et al, 2009). Lower socio-economical status was related to an 
inadequate behavior concerning folic acid supplements (no intake or less than 
recommended intake) in 2 studies conducted in Ireland and The Netherlands (McGuire et al, 
2010; Timmermans et al, 2008). At the same time, high level of education in women of 
childbearing age was associated with a high level of folic acid intake (Nasr Hage et al, 2011; 
Nawapun and Phupong, 2007; CDC, 2008). 
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Being married was frequently identified as a factor of high folic acid intake. Cleves and 
colleagues found that married women were almost twice more likely than single women to 
take a daily supplement (Cleves et al, 2004). In the Netherlands, 42% of married women 
used folic acid supplement as compared  to 10% of single women (p<0.001) (Timmermans et 
al, 2008). Another factor related to folic acid usage is the planning of pregnancy. Studies 
have shown that women who intended their pregnancies were 3 times more likely to use 
adequately folic acid supplements than women with unintended pregnancies (Rosenberg et 
al, 2003). In Europe, countries such as Norway and Ireland, studies have shown a higher 
chance of folic acid usage among women with planned pregnancies compared to unplanned 
pregnancies (McGuire et al, 2010; Nilsen et al, 2006). A planned pregnancy was also a factor 
related to supplements consumption in non-western countries such as Lebanon and Korea 
(Kim et al, 2009; Nasr Hage et al, 2011). The impact of this factor increases with the 
proximity of the planned conception, with women who indicate their desire to become 
pregnant at some time in the future but with no specific plan, being no more likely to take a 
daily folic acid supplement than women never wanting to become pregnant (Cleves et al, 
2004). The number of pregnancies was also found as a determinant of folic acid intake with 
women having had anterior pregnancies more likely to take folic acid supplements than 
women with their first pregnancy (Carmichael et al, 2006; Nasr Hage et al, 2011; Nilsen et al, 
2006). Only one study conducted in Australia by Forster and his colleagues showed that 
having had other pregnancies is correlated with lower levels of folic acid intake (Forster et 
al, 2009). National studies in the USA showed that the pregnancy status was also a factor 
influencing positively the chance of folic acid intake (CDC, 2008).  
Age is a very important factor in relationship with folic acid for many reasons. In the USA, 
women in the age of 18-24 years account for one third of all births. At the same time, studies 
have shown that this age group had the least awareness and knowledge about folic acid and   
the lowest reported daily use of supplements (Morin et al, 2002; CDC, 2008; Timmermans et al, 
2008). Furthermore, women in this age group have multiple risk factors for inadequate folic 
acid consumption. They have a high rate of unintended pregnancies, reaching 80% of all 
pregnancies in this age group (Finer and Henshaw, 2006) and they adopt risky sexual 
behaviors, not using systematically birth controls in about 1 in 5 women (Chandra et al, 2005). 
In this age group, women have also the lowest median annual household income (DeNavas-
Walt et al, 2006) and often haven’t completed college. They engage in unhealthy dietary 
behavior and often fail to meet dietary intake recommendations (Anding et al, 2001). All these 
behavioral, economical, educational and nutritional factors contribute to the low level of folic 
acid consumption in this age group and to the increased risk of pregnancies affected by NTDs. 
One study found that women aged 14-19 years were twice as likely to have a pregnancy with 
NTD as women 25-29 years of age (Reefhuis and Honein, 2004). It is of noteworthy to highlight 
the fact that all these studies in this age group were conducted in western countries where 
sexual activities and pregnancies in young, single women are socially accepted in opposition 
to more conservative societies where data on this subject is lacking.  
An interesting study conducted by Ahluwalia and his collegues showed that certain 
psychosocial factors as well as advice from a health care provider help women to make 
decisions about folic acid use (Ahluwalia et al, 2007). In this study, regular use of 
multivitamins was positively associated with perceived benefits and negatively associated 
with perceived barriers. 
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5.2 Strategies to improve folic acid use 
In the years following the folic acid recommendations, many educational and promotional 
campaigns using different means of communication have been used to promote folic acid 
intake during the periconceptional period with variable results. A systematic review of the 
literature on interventions designed to improve knowledge, awareness and consumption 
concerning folic acid was conducted in 2007 (Chivu et al, 2007). Among consumers, the 
interventions studied were printed and audio-visual media (radio, TV, internet) and printed 
media with other channels such as counseling, free distribution of folic acid pills, 
advertisements, magnetized reminders, food labels (folate logo and messages from 
nutritionists on food packs), slide presentations and reminder phone calls. Among health 
professionals, the interventions studied consisted of printed materials, training, professional 
publications, letters, personal communication, incentives (coffee mugs, note pads) and 
reminder in the patient history form. The review showed that health professionals increased 
their knowledge about folic acid advised dose from 13 to 58% before intervention to 51% to 
70% after intervention and about the recommended period for folic acid usage from 57% to 
80% before intervention to 79% to 85% after intervention (p<0.0001). Also, 19% to 62% of 
health professionals were recommending folic acid to women after the intervention, as 
compared to 13% to 45% before the intervention. As for women, awareness concerning folic 
acid increased on average from 60% to 72%, knowledge increased from 21% to 45% and 
consumption increased from 14% to 23%. Even though variable interventions increased 
women’s knowledge and awareness of folic acid, there were still wide discrepancies 
between awareness/knowledge and consumption. Studies have shown that, according to 
social marketing theory, mass media positively influences people’s awareness and 
knowledge, whereas behavior is more influenced by things such as health professionals’ 
counseling and interpersonal communication (Roger, 2003).  
Many European countries have launched official educational campaigns on folic acid and its 
role in the prevention of NTDs. In Belgium, the ONE (Office Of Birth and Childhood) in 
association with ASBBF (Association Spina Bifida Belge Francophone) ran a campaign 
including leaflets, a website, information on radio and television and letters to gynecologists 
and family physicians about the benefits of periconceptional folic acid . After the campaign, 
a study was conducted in 2006 on 195 women in the first week after delivery. It showed a 
percentage of folic acid consumption before and during pregnancy of only 12% (EUROCAT, 
2009). In Denmark, the Danish Veterinary and Food Administration published leaflets 
addressing women planning pregnancy and distributed them to clinics, hospitals, 
pharmacies and drugstores in 1999 and again in 2001.At the same time, a study on 
compliance with folic acid guidelines was launched in 2000 until 2002 and was able to 
evaluate the impact of the health education campaign on folic acid usage. This study 
showed an increase in the proportion of women complying with the recommendation after 
the campaign. However, even at the end of the period, only 22% of the women with planned 
pregnancies were following the recommendations on folic acid supplementation (Knudsen 
et al, 2004). In Germany, there are no official governmental guidelines on periconceptional 
folic acid and no official health education campaigns. However, in Munich, a non official 
campaign on folic acid took place from 1996 to 1998. The impact of this campaign was 
evaluated by measuring periconceptional folic acid intake. This study showed an increase of 
intake from 2% in 1996 to 5% in 1998. Still, the percentages reached for folic acid 
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consumption were excessively low (Egen, 1999 as cited in EUROCAT, 2009). In Ireland, 
since the recommendations on the consumption of folic acid tablets were issued in 1993, 
many promotional campaigns were undertaken at the national level through periodic media 
campaigns. At a more local level, health promotion units and public health departments 
promoted folic acid through a variety of channels, usually on an on-going basis. Studies 
evaluating the impact of these campaigns showed that even though women’s awareness and 
knowledge concerning the role of folic acid in NTD prevention have reached high levels 
(95% and 77% respectively in 2002), the consumption of periconceptional folic acid was very 
low and not improving , being 21% in 1998 and reaching only 23% in 2002 (Ward et al, 2004). 
In Sweden, since 2007, the Board of the National Food Administration is sending annual 
letters to all women 18-45 years of age with information on the link between folic acid and 
the risk of NTDs, in addition to an offer of free folic acid tablets. No Study was conducted in 
Sweden to evaluate the efficacy of this campaign (EUROCAT, 2009). 
6. Health professionals’ knowledge and behavior concerning folic acid 
Some studies found that health professionals play a major role in folic acid usage by women 
of childbearing age. The survey conducted by the March of the Dimes Foundation showed 
that 42% of women, aware of folic acid but not consuming it, would take a multivitamin if 
advised to do so by a health professional (March of the Dimes, 2004). In the 2004 Health 
Styles Survey, 91% of women 18-45 years of age agreed to take a multivitamin daily to 
prevent NTDs if their doctor encouraged them (Williams et al, 2006). In order to evaluate 
health professionals’ knowledge and practice, the CDC initiated a national study in USA in 
2001 among obstetricians/gynecologists, family/general physicians, nurse practitioners, 
certified nurse midwives, physician assistants and registered nurses (Williams et al, 2006). 
The study showed that more than 85% of the health care professionals knew about the 
adequate time to use folic acid supplements and that these supplements were necessary 
beyond what is available in diet. At the same time, 42% of the health professionals surveyed 
did not know the correct folic acid dosage. Nurse practitioners were most likely and 
family/general doctors were least likely to recommend supplements. The strongest 
predictor for recommending supplements was the personal intake of multivitamins by the 
health professional. Since incorporating messages about folic acid into preventive health 
care messages is critical to increasing folic acid consumption, health professionals were 
asked if they addressed folic acid intake during well-women visits. More 
obstetricians/gynecologists than family/general practitioners said they mentioned folic acid 
regularly to women (65% v/s 50% respectively).  The conclusion of this study was that even 
though knowledge among health professionals concerning folic acid was good, this 
knowledge did not necessarily translate into counseling patients about its benefits. 
Consistent with these results, 2 other studies conducted in the USA showed that even 
though health care providers were aware of the importance of folic acid in the prevention of 
NTDs, only half of them discussed folic acid on a regular basis with women of childbearing 
age (Hauser et al,2004; Power et al, 2000). A pilot study conducted in Ontario, Canada 
showed that 43% of family physicians did not mention folic acid supplementation as a topic 
for discussion with women of childbearing age, with women actually planning pregnancies 
or with women in the first trimester of pregnancy (Pereleman et al, 1996). The same study 
showed that up to 40% recommended folic acid to an already pregnant woman, and 10% 
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recommend it only to pregnant women. Only 14% of physicians in this study had correct 
knowledge of the appropriate dosages and timing for folate supplements and only 17% of 
all contacted physicians recommended folate to any women of childbearing age. In Puerto 
Rico, 88% of primary care physicians demonstrated an inadequate knowledge about folic 
acid supplements with older physicians and women physicians demonstrating greater 
knowledge than other physicians in the study (Mirinda et al, 2003). In Israel, 2 studies 
evaluated physicians’ knowledge and practice concerning folic acid. The first study showed 
that 94% of physicians recommended folic acid to their patients but knowledge in this study 
was insufficient since only 2% correctly estimated the efficacy of folic acid in decreasing 
NTDs, 12% knew about the adequate timing and 47% about the correct dosage of folic acid 
supplements (Abu–Hamad et al, 2008). Another study conducted among women and 
physicians in Israel showed that 87% of gynecologists recommended preconception folic 
acid compared to 60% of family physicians (p<0.05)  (Auriel et al, 2011). In Germany, a 
study done in 1996 showed that only 38% of gynecologists in Munich recommended 
preconceptional folic acid, 8% recommended folic acid at the beginning of pregnancy, 17% 
recommended folic acid only in cases with family history of NTDS and 37% did not give any 
recommendation at all. Following an interventional campaign in 1998, 74% of gynecologists 
recommended preconceptional folic acid. However, there were still 15% of gynecologists 
who recommended folic acid with the beginning of pregnancy and 11% only in case of a 
family history (Egen, 2000 as in EUROCAT, 2009). 
7. Conclusion 
There is strong evidence that most NTDs are preventable by increasing folate status before 
conception. Responses to this evidence have been variable around the world. Many 
governments have issued recommendations regarding the necessity for women to take folic 
acid, from at least 1 month before conception and during the first 3 months of pregnancy. 
Up to 53 countries around the world issued regulations for mandatory folic acid fortification 
of staple food. These countries had the most reduction in NTD prevalence according to 
registries. Even though this was a success story, it was considered as a partial success since 
the reduction seen with fortification was less than the reduction seen in studies using folic 
acid supplements. This was the reason behind the recommendations for folic acid 
supplements during the periconceptional period, at the dose of 400-500µg/day for women 
with no history of NTDs and at the dose of 4-5 mg/day in case of family history or previous 
personal pregnancies with NTDs. Health education campaigns on local and national were 
launched in many countries with variable results. These campaigns have been mainly 
effective on increasing the knowledge and awareness of women concerning folic acid. Still, 
the actual intake of folic acid is quiet low during the periconceptional period. All these facts 
show that women’s behavior is complex and influenced by many determinants. A package 
of different measures including actions targeting women and health professionals are 
needed in order to improve intake of folic acid by women of childbearing age.  
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